Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Alieva, Maria ^a   Margarido, Andreia S ^a   Wieles, Tamara ^a   Abels, Erik R ^b   Colak, Burcin ^a   Boquetale, Carla ^a   Jan Noordmans, Herke ^a   Snijders, Tom J ^a   Broekman, Marike L ^a,b   Van Rheenen, Jacco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CCL2 PROTEIN, HUMAN; DENDRA2 PROTEIN, DENDRONEPHTHYA; DEXAMETHASONE; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOTOPROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOPSY; BRAIN EDEMA; BRAIN TUMOR; CELL MOTION; DISEASE EXACERBATION; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; MORTALITY; MOUSE; PATHOLOGY; REPORTER GENE; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; STEREOTACTIC PROCEDURE; SURVIVAL ANALYSIS; TIME LAPSE IMAGING; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BRAIN EDEMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL2; DEXAMETHASONE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; INFLAMMATION; LUCIFERASES; LUMINESCENT PROTEINS; MACROPHAGES; MICE; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; STEREOTAXIC TECHNIQUES; SURVIVAL ANALYSIS; TIME-LAPSE IMAGING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85027135273     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07660-4     Document Type: Article

References (54)

1. Heuckmann, J. M. & Thomas, R. K. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 26, 1830-1837 (2015).
2. Tomlins, S. A., Palanisamy, N., Siddiqui, J., Chinnaiyan, A. M. & Kunju, L. P. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. Archives of pathology & laboratory medicine 136, 935-946 (2012).
3. van Malenstein, H. et al. Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma. Hepatology research: the official journal of the Japan Society of Hepatology 42, 990-998 (2012).
4. Predina, J. et al. Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery. Proceedings of the National Academy of Sciences of the United States of America 110, E415-424 (2013).
5. Lange, P. H., Hekmat, K., Bosl, G., Kennedy, B. J. & Fraley, E. E. Acclerated growth of testicular cancer after cytoreductive surgery. Cancer 45, 1498-1506 (1980).
6. Nijkamp, M. W. et al. Prolonged portal triad clamping during liver surgery for colorectal liver metastases is associated with decreased time to hepatic tumour recurrence. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 36, 182-188 (2010).
7. Jin, X. et al. Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain: a journal of neurology 135, 1055-1069 (2012).
8. Mathenge, E. G. et al. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia 16, 950-960 (2014).
9. Stroncek, J. D. & Reichert, W. M. Overview of Wound Healing in Different Tissue Types. in Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment (ed. Reichert, W.M.) (2008).
10. Nguyen, D. T., P., O. D. & T., M. G. Biomaterials For Treating Skin Loss. in Biomaterials for Treating Skin Loss (Woodhead Publishing 2009).
11. Parsa, A. T. et al. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. Journal of neurosurgery 102, 622-628 (2005).
12. Ellenbroek, S. I. & van Rheenen, J. Imaging hallmarks of cancer in living mice. Nature reviews. Cancer 14, 406-418 (2014).
13. Kedrin, D. et al. Intravital imaging of metastatic behavior through a mammary imaging window. Nature methods 5, 1019-1021 (2008).
14. Janssen, A., Beerling, E., Medema, R. & van Rheenen, J. Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy. PloS one 8, e64029 (2013).
15. Osswald, M. & Winkler, F. Insights into cell-to-cell and cell-to-blood-vessel communications in the brain: in vivo multiphoton microscopy. Cell and tissue research 352, 149-159 (2013).
16. Coussens, L. M., Zitvogel, L. & Palucka, A. K. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286-291 (2013).
17. Wyckoff, J. et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer research 64, 7022-7029 (2004).
18. Patsialou, A. et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colonystimulating factor-1 receptor. Cancer research 69, 9498-9506 (2009).
19. Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nature reviews. Immunology 11, 762-774 (2011).
20. Auffray, C., Sieweke, M. H. & Geissmann, F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annual review of immunology 27, 669-692 (2009).
21. Sunderkotter, C. et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. Journal of immunology 172, 4410-4417 (2004).
22. Polfliet, M. M. et al. A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. Journal of neuroimmunology 116, 188-195 (2001).
23. Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222-225 (2011).
24. Dal-Secco, D. et al. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. The Journal of experimental medicine 212, 447-456 (2015).
25. Graber, D. J., Costine, B. A. & Hickey, W. F. Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets. Journal of neuroinflammation 12, 76 (2015).
26. Lee, S. et al. Effect of a broad-specificity chemokine-binding protein on brain leukocyte infiltration and infarct development. Stroke; a journal of cerebral circulation 46, 537-544 (2015).
27. Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nature medicine 20, 1147-1156 (2014).
28. Kostaras, X., Cusano, F., Kline, G. A., Roa, W. & Easaw, J. Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline. Current oncology 21, e493-503 (2014).
29. Yasuhiko Ohkaru et al. Acute and Subacute Effects of Dexamethasone on the Number of White Blood Cells in Rats. Journal of Health Science 56, 5 (2010).
30. Gustafson, M. P. et al. Systemic immune suppression in glioblastoma: the interplay between CD14+ HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro-oncology 12, 631-644 (2010).
31. Badie, B. et al. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. Journal of neurosurgery 93, 634-639 (2000).
32. Coffey, J. C. et al. Excisional surgery for cancer cure: therapy at a cost. The Lancet. Oncology 4, 760-768 (2003).
33. Szalayova, G. et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast cancer research and treatment 157, 461-474 (2016).
34. Lundstedt, C., Stridbeck, H., Andersson, R., Tranberg, K. G. & Andren-Sandberg, A. Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta radiologica 32, 518-520 (1991).
35. Wijnenga, M. M. J. et al. Does early resection of presumed low-grade glioma improve survival? A clinical perspective. Journal of Neuro-Oncology (2017).
36. Bogani, G. et al. Morcellator's Port-site Metastasis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential After Minimally Invasive Myomectomy. Journal of minimally invasive gynecology 23, 647-649 (2016).
37. Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67 (2010).
38. Massague, J. TGFbeta in. Cancer. Cell 134, 215-230 (2008).
39. Lewis, C. E. & Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. Cancer research 66, 605-612 (2006).
40. Huysentruyt, L. C., Akgoc, Z. & Seyfried, T. N. Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme? ASN neuro 3 (2011).
41. Keklikoglou, I. & De Palma, M. Cancer: Metastasis risk after anti-macrophage therapy. Nature 515, 46-47 (2014).
42. Cuddapah, V. A., Robel, S., Watkins, S. & Sontheimer, H. A neurocentric perspective on glioma invasion. Nature reviews. Neuroscience 15, 455-465 (2014).
43. Bardehle, S. et al. Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nature neuroscience 16, 580-586 (2013).
44. Nakagawa, M. et al. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 98, 2307-2313 (1998).
45. Zen, M. et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmunity reviews 10, 305-310 (2011).
46. Wong, E. T., Lok, E., Gautam, S. & Swanson, K. D. Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. British journal of cancer 113, 1642 (2015).
47. Pitter, K. L. et al. Corticosteroids compromise survival in glioblastoma. Brain: a journal of neurology 139, 1458-1471 (2016).
48. Goswami, K. K. et al. Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cellular immunology 316, 1-10 (2017).
49. Winter, S. F., Loebel, F. & Dietrich, J. Role of ketogenic metabolic therapy in malignant glioma: A systematic review. Critical reviews in oncology/hematology 112, 41-58 (2017).
50. Alieva, M. et al. Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. PloS one 7, e35148 (2012).
51. Alieva, M., Ritsma, L., Giedt, R., Weissleder, R. & van Rheenen, J. Imaging windows for long-term intravital imaging: General overview and technical insights. Intravital 3 (2014).
52. Noordmans, H., de Roode, R., Staring, M. & Verdaasdonk, R. Registration and analysis of in-vivo multispectral images for correction of motion and comparison in time. in Multimodal Biomedical Imaging (Proc. SPIE 6081, 2006).
53. Gligorijevic, B., Kedrin, D., Segall, J. E., Condeelis, J. & van Rheenen, J. Dendra2 photoswitching through the Mammary Imaging Window. Journal of visualized experiments: JoVE (2009).
54. Ritsma, L. et al. Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Science translational medicine 4, 158ra145 (2012).